about
Graphite Bio Inc is a clinical-stage gene-editing company harnessing gene integration to develop a new class of therapies to cure serious and life-threatening diseases. Its gene-editing platform allows to precisely correct mutations, replace entire d...
Read More
25.60
-0.89
(-3.36%)
1.1M
XNAS Volume
XNAS 14 Nov, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
Graphite Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..